Furthermore, the reduction of glutamate release induced by gabapentin might modulate the occupancy of the metabotropic glutamate receptor 1 (GRM1), as well as the NMDA receptor, which seems to induce spontaneous melanoma development in vivo [59,60,61] and melanoma growth [62]. This evidence concerns the gene GRM1 and melanoma.